Celanese CORP Schedule 13G passive stakes

Norges Bank has reported a beneficial ownership of 8.7955% in Celanese Corp's common stock as of June 30, 2026, holding 9,645,359 shares.

Norges Bank has reported beneficial ownership of 6,924,205 shares, representing 6.1866% of Celanese Corp's common stock as of March 31, 2026.

Vanguard Capital Management has reported beneficial ownership of 5.15% of Celanese Corp's common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 5.65% in Celanese Corp's common stock as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Celanese Corp following an internal realignment.

Capital Research Global Investors has reported a 5.1% beneficial ownership stake in Celanese Corp. common stock as of December 31, 2025.

Norges Bank, Norway's central bank, has disclosed a 2.4% beneficial ownership stake in Celanese Corp, holding over 2.5 million common shares.

Investment adviser Dodge & Cox has filed an amended Schedule 13G, disclosing a continued 13.8% beneficial ownership stake in Celanese Corporation's common stock as of March 31, 2025.

Capital International Investors has filed an amended Schedule 13G, reporting a 3.0% beneficial ownership stake in Celanese Corp. as of March 31, 2025.

The Vanguard Group has filed an amended Schedule 13G, reporting a 10.74% beneficial ownership stake in Celanese Corp's common stock as of March 31, 2025.

Norges Bank, acting on behalf of the Government of Norway, has disclosed a 7.6% beneficial ownership stake in Celanese Corp, holding 8,498,908 shares as of March 31, 2025.

BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 11.2% of Celanese Corp's Class A Stock as of March 31, 2025.

Capital International Investors has filed an amended Schedule 13G, revealing a 6.8% beneficial ownership stake in Celanese Corp. as of December 31, 2024.

Investment advisor Dodge & Cox has reported a 12.5% beneficial ownership stake in Celanese Corporation's common stock as of December 31, 2024, held for investment purposes.

Capital Research Global Investors has filed an amended Schedule 13G, disclosing a reduction in its beneficial ownership of Celanese Corp. common stock to 4.2% as of December 31, 2024.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a 1.3% beneficial ownership stake in Celanese Corporation's Series A Common Stock as of December 31, 2024.